Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 135,821 | 135,029 | 52,071 | 61,031 | 45,072 |
| Marketable Securities | 252,443 | 331,830 | 380,742 | 306,709 | 267,057 |
| Receivables | 34,155 | 33,512 | 32,467 | 30,036 | 26,367 |
| Inventories | 1,357 | 1,194 | 1,025 | 1,280 | 1,140 |
| TOTAL | $432,946 | $519,292 | $478,301 | $409,145 | $354,136 |
| Non-Current Assets | |||||
| PPE Net | 2,037 | 2,573 | 3,113 | 4,136 | 3,864 |
| Intangibles | 121,369 | 18,565 | 20,081 | 21,559 | 23,037 |
| Other Non-Current Assets | 92,088 | 93,817 | 92,297 | 98,616 | 102,711 |
| TOTAL | $215,494 | $114,955 | $115,491 | $124,311 | $129,612 |
| Total Assets | $648,440 | $634,247 | $593,792 | $533,456 | $483,748 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 38,460 | 45,551 | 34,438 | 31,509 | 27,590 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 31,915 |
| Other current liabilities | 49,237 | 45,885 | 39,981 | N/A | N/A |
| TOTAL | $87,697 | $91,436 | $74,419 | $65,936 | $59,505 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 34,427 | N/A |
| Other Non-Current Liabilities | 15,833 | 15,613 | 14,445 | 14,254 | 13,298 |
| TOTAL | $15,833 | $15,613 | $14,445 | $14,254 | $13,298 |
| Total Liabilities | $103,530 | $107,049 | $88,864 | $80,190 | $72,803 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,538 | 56,785 | 55,907 | 54,883 | 53,649 |
| Common Shares | 58 | 57 | 56 | 55 | 54 |
| Retained earnings | -155,392 | -157,901 | -164,176 | -197,328 | -220,665 |
| Other shareholders' equity | -30 | -1,193 | -175 | 239 | 249 |
| TOTAL | $544,910 | $527,198 | $504,928 | $453,266 | $410,945 |
| Total Liabilities And Equity | $648,440 | $634,247 | $593,792 | $533,456 | $483,748 |